Amid heated debate, FDA hands limited nod to Pfizer for COVID-19 vaccine boostersnews2021-09-23T13:40:33+00:00September 23rd, 2021|Fierce Pharma|
On a JAK roll, Incyte wins FDA green light to expand Jakafi in chronic graft-versus-host diseasenews2021-09-23T13:14:04+00:00September 23rd, 2021|Fierce Pharma|
Pfizer CEO Bourla asks employees to join the scrum for D.C. drug-pricing fightnews2021-09-23T13:08:14+00:00September 23rd, 2021|Fierce Pharma|
Takeda breaks ground on $14M green building at Singapore manufacturing plantnews2021-09-23T12:47:52+00:00September 23rd, 2021|Fierce Pharma|
Do not enter: Biogen reps banned from D.C.-area neurology clinics over controversial Alzheimer’s drug Aduhelmnews2021-09-22T20:46:30+00:00September 22nd, 2021|Fierce Pharma|
Small but formidable activist investor Bluebell takes stake in GlaxoSmithKline, asks CEO Walmsley to reapply for job: FTnews2021-09-22T20:23:41+00:00September 22nd, 2021|Fierce Pharma|
The unvaccinated are mostly young and non-political, a study finds. Time for pharma to switch up media outreach?news2021-09-22T20:09:49+00:00September 22nd, 2021|Fierce Pharma|
The unvaccinated are mostly young and nonpolitical, a study finds. Time for pharma to switch up media outreach?news2021-09-22T20:09:49+00:00September 22nd, 2021|Fierce Pharma|
Reckitt’s Mucinex ushers in cold and flu season with tribute to Latinos making a differencenews2021-09-22T17:07:16+00:00September 22nd, 2021|Fierce Pharma|
Lonza’s march of manufacturing expansion continues with more backyard plansnews2021-09-22T15:58:19+00:00September 22nd, 2021|Fierce Pharma|
